Vanda Pharmaceuticals | VNDA - 市值



金融业
股票价格
USD
资产
USD 488.95M
现金及等价物
USD 84.85M
销售成本
USD 198.77M
流动资产
USD 347.26M
流动负债
USD 145.16M
债务
USD 4.96M
股息收益率
0
EBIT
USD -10.28M
EBITDA
USD -8.31M
员工
203
EPS每股收益
USD -0.09
股本和储备
USD 327.19M
销售毛利
USD 50.6M
债务利息支出
-1.37B
贷款资金
USD 3.15M
市值
USD 356.2M
净收入
USD -18.9M
营业费用
USD -1.14B
营业利润
USD -40.66M
普通股股本
USD 58K
PE价格收益
16.79
税前利润
USD -22.92M
销售收入
USD 198.77M
销售和管理费用
USD 39.28M
股票
USD 1.85M
贸易债权人
USD 39.09M
应收帐款人
USD 47.1M


市值 更改 日
Acadia Pharmaceuticals USD 3.57B 221M 2026-05
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.7B 920M 2026-05
AstraZeneca USD 301.25B 13.1B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Enanta Pharmaceuticals USD 122M 98M 2024-12
Esperion Therapeutics USD 885M 351M 2025-12
Halozyme Therapeutics USD 8.56B 905M 2026-05
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 15.56B 19.73B 2026-05
J&J USD 579.15B 78.91B 2026-03
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Ligand Pharmaceuticals USD 3.72B 257M 2026-05
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Pfizer USD 147.4B 6.42B 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Sanofi EUR 100.27B 605.48M 2026-03
Takeda JPY 8.33T 681.01B 2026-05
Teva Pharmaceutical Industries USD 34.27B 2.14B 2026-03
Ultragenyx Pharmaceutical USD 2.06B 1000K 2026-05
Vanda Pharmaceuticals USD 279M 6M 2024-12
Veracyte USD 2.59B 16M 2026-05